Back

Are your atrial fibrillation (AF) patients protected from ischaemic stroke? Clinical characteristics of AF patients eligible for stroke prevention but remaining untreated in UK clinical practice

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation II Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Essra Ridha

Bristol-Myers Squibb Pharmaceuticals Limited , London (United Kingdom of Great Britain & Northern Ireland)

22 More presentations in this session

Presentation thumbnail
Doctor E. Ridha (London, GB)
Abstract Slides
Presentation thumbnail
Doctor A. Nissen Bonde (Roskilde, DK)
Presentation thumbnail
Doctor E. Nguyen (Storrs, US)
Abstract Slides
Presentation thumbnail
Doctor G. Laugaudin (Montpellier, FR)
Abstract
Presentation thumbnail
Professor J. Piccini (Durham, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation II

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources